Ceo Neville vs Ceo Culley.
Neville is a successful serial entrepreneur, Culley a serial collector of flops.
Neville sold is software company for $100mil, and likely he put his millions in Savara, Culley never invested real money in MSTX or ANX.
We don't know the Neville wage but we know that Culley costs us over $1.5 mil/year

Market closed.
Lol

The Amex rules for the Reverse Merger need a R/S. This is quite inevitable, but in any case shouldn't lower the stock because based on evaluation of $37million of the Mast business from Savara.
I'm not sure, but I think Amex asks at least $4 a share to permit the RM.
I'm extremely bullish on Mast and consider this pps under .25 good for accumulation or to entry.

http://100fstreet.com/index.php/2011/11/the-sec-approves-additional-nyse-nasdaq-and-amex-listing-requirements-for-reverse-merger-companies/

from MSTX to SAVA.
from Culley to Neville.

My DD in a nutshell.

I think Sabby Hedge are long, they bought around 0.16 corresponding to $37M market capitalization, unless some insider information about something of very bad for pps, $37M mc is too low to short for a real profit, likely they are long, at least for this phase

Hedge like Sabby bought massively holding the pps low, tomorrow will be better

Shareholders will benefit greatly from Savara merger. Biggest upside is after merger closing
The new Leny's blog on merger valuation, very informative
http://seekingalpha.com/instablog/44479986-leny-hettmansperger/4948418-mstx-shareholders-will-benefit-greatly-savara-merger-biggest-upside-merger-closing

agreed Pray, we are still paying for Cully operations, the never ending dilutions and his millionaire fee. So bad reputation of Mast stock is still active and is slowing down the pps rise, still poor confidence.
Culley replacement is one of the best catalyst for the near future, I hope new Ceo Neville made himself heard more about newco plans, maybe we see 0.50 again before merger approval.

why did Mast keep hidden the trial of AIR001 on cystis fibrosis?
This is P1/2 trial that will finish this month, it seems AIR001 very effective Vs Pseudomonas aeruginosa bacteria in cystic fibrosis also in combo with antibiotics.
Savara will begin soon a P3 in Cystis Fibrosis with its antibiotics AeroVanc against Pseudomonas aeruginosa .
You think this is mere happenstance?
I think that this was an old agreement, and Culley now gave AIR001 in change of something in the newco. We'll see soon how the newco is composed.

Next announcement AIR001 results for Cystis Fibrosis bacteria and then a P3 with AeroVanc combo super-drug .

https://clinicaltrials.gov/ct2/show/NCT02694393

I well remember of you on YMB. Quite honestly you won by knockout the round about EPIC, I and other investors lose, but, as you know, I think we have to separate every drug and story. I hope, and I'm pretty sure, this time there will be a very different conclusion for several reasons.
-AIR001 trials aren't clinically managed and sponsored by Mast:great thing.
-then their results cannot be tempered with, as usually happen in the P2.
-Culley hasn't other real possibilities, and if a R/M he could resign, also a partnership could reduce his control on the Co.
-Usually a R/M transforms radically the public company.

Now my concerns are if Culley really wants a good merger/partnership losing power rather than a mediocre solution maintaining power and salary.

last chance for Culley to avoid a totally inglorious exit and a sequence of lawsuits

Ceo Culley masterpiece

Mast's Ceo: the most payed clown ever. $1.9 M /year with bonus

My concern is that Culley wants to stay at any cost, by limiting in fact the sale of the Company or the best solution for stockholders.
I think that is very easy sell Mast around 200 M or even much more if only the Amex ticket and AIR001. But I think Culley doesn't want that.
In any case be ready for a legal action.

for sure, pray, Culley is able to play with investors patience and never invests in the company his money. Is this the last act of the drama?
Can Culley save is job and salary again?
I think he can but only if he comes up with a solution that exploit the full potential of AIR in cardiology and the stock goes back to dollar zone.
Last opportunity,law suite always ready in the drawer

for sure, pray, Culley is able to play with investors patience and never invests in the company his money. Is this the last act of the drama?
Can Culley save is job and salary again?
I think he can but only if he comes up with a solution that exploit the full potential of AIR in cardiology and the stock goes back to dollar zone.
Last opportunity,law suite always ready in the drawer

Ceo Corner.
Updated soon.
Finally news on merger?
http://masttherapeutics.com/about-us/ceo-corner/

The news expected any day, in order of rising importance:
-Vepoloxamer database sold
-partnership for combo therapy with Vepoloxamer
-partnership for the Vepoloxamer in stroke
-partnership for AIR001
-Reverse Merger
-Buyout

Likely yesterday they signed something, if no a PR today and the stock dumps it's only mean that they cannot make it public yet and the rise was due to a leak.

News expected in order of rising importance:
-Vepoloxamer database sold
-partnership for the Vepoloxamer in SCD
-partnership for the Vepoloxamer in stroke
-partnership for AIR001
-Reverse Merger
-Buyout

Do you think that we'll finally change the CEO? The reverse merger is with a private company greater and healthier than Mast, this likely entails that the private company imposes part of its management usually also the CEO.
For once in his CEO life Culley could do the right thing selling high AIR001 and the other Mast's assets, adding cash and maybe expanding the pipeline and the skills,and if moreover he will do a step down, that's the icing on the cake.

$MSTX how much does the MSTX management cost? Culley alone compensation is $ 1.8M or 10% of the Market Cap, I think that the management costs is above the 25-30% of the current market capitalization!
That's a great point in case of possible lawsuit: the disproportionate compensations of the executives and management Vs the financial situation and Vs SHs investments

pray, Culley seems finally interest to SH money. He repeated in the last 2 PRs
"which can bring value to shareholders"
"which we believe could maximize returns for our stockholders"
Perhaps he fears lawsuits from exhausted SHs,lawsuit would be very bad for all in a moment of transition. Perhaps he wants to safe is CEO seat, merger can be a total revolution for the little Mast

The last PR could've been an attempt of Culley to raise the bid price of the merger/BO among the interested companies or to expand the knowledge of the offer. I don't exclude he did that also for fear of some lawsuits.
Likely Culley was coerced by institutional investors to find a solution that could radically change the control of the company,changing part of the management,the BOD and maybe the Ceo too..
Surely the reverse merger can be also an easy solution of all Ceo problems but also for the shareholders the R/M can clearly increase the pps immediately and in the medium-term, of course if done with the right company. They have several offers , that's good,and I don't think,as you say, that Culley can afford to be smart with institutional now, they have to choose the best offer not only as cash but also as value resulting of the new company after the merger. Unless there is a BO it would be best a merger with a Co with already sales or a drug near to market, better if cardiac.
We'll see soon,by December imo.

I don't see all this negativity about a R/S at this shameful price.
RS is bad when a stock is overvalued and with a high capitalization not when extremely undervalued as Mast.
In any case I think that if there will be a merger at the same time also the number of shares will be arranged. That's quite obvious.

We don't know how many offers there are or there have been, for sure nothing should leak until the day of the PR

yesterday CC: important points about merger/BO "We also are exploring a range of strategic opportunities from collaborations and licensing arrangements to being acquired in a merger or a sale of part or all of our assets. And as part of our commitment to create value this way. We recently engaged an investment bank as a financial advisor to assist in identifying evaluating and negotiating these opportunities for Mast, which we believe can establish a new and exciting future for current Mast shareholders."

Culley R/S immediately, please! Put in a safe place the company against delisting risk, until merger,BO partner...

CC speaking about merger

In some case it worked, I don't remember the socks but I already saw it, surely few exceptions. I think this is our case, avoid delisting risk is a catalyst

Unless important news about business the R/S wouldn't be a bad solution.
Above all because traded at or below the cash. Imo a RS shouldn't down the PPS because fixed by the cash and with the effect to dispel any worries about delisting. In addition whichever partnership/merger/BO are based on the values, market cap.. not on PPS.

Tuesday earning conference can be the turning point of this reorganization phase after the epic fail, if finally all planets are aligned to restart towards the promises of AIR in HF or instead continue to languish as trash few cents stock for months/years. In other words if Culley/BOD are determined to loss part of their power in favor of a third party, for a predominant partnership unless even a merger/bo.
My hope is the entrance of a big pharma, I bid on the Novartis return or Bayer and Merck.

double or triple on this news it's difficult,also because the today positive result were expected.
Surely x2,x3 or more if this news is associate with good news about finance or better about partnership for P3.
This news alone is worth a 20% ,still too many negative heritage on the company executives.

Hello Chris, my opinion on Mast is close your unless about Ceo. I'm worried about this guy, his behavior is not clear and not honest,poor confidence.
I always remember the scam of Vepo dancers on Youtube.
Lu24IX

I can't read the article due to subscription,they title:"Mast Therapeutics Inc (NYSEMKT:MSTX) Scheduled 3Q2016 Financial Results and Signs Collaboration Agreement For AIR001"
Do you know which agreement are they speaking?

this is the article that Culley spoke Sept 26 at business update conference, not the P2 results yet.
P2 should end soon and this surely will be good for PPS. The article on JCI,a prestigious medical journal, can help Mast to find the partnership and put AIR001 in the limelight.
I think impossible that important Pharma Companies haven't noticed AIR001 and its potential, today 5,6 millions in US and 20 millions worldwide patients have HFpEF an unmet med disease. I'm surprised that a bids war not started yet. Let's hope talks are in progress.

in 2 days the new article on AIR001
https://insight.jci.org/articles/view/89620

I think it could work or at least is one of the best possibility for the retail SHs, we need a person willing to become the representative, if able to talk with the company should the best. Unfortunately I'm not in US and my English is poor

I think it could work or at least is one of the best possibility for the retail SHs, we need a person willing to become the representative, if able to talk with the company should the best. Unfortunately I'm not in US and my English is poor